Life & Brain

Focus: Life & Brain is a German biotech R&D specialist focused on cellomics, genomics, and neurocognition research, with a neurology-focused therapeutic pipeline. Founded in 2002 and headquartered in Bonn, the company operates as a research-driven biotech with modest scale.

Neurology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Life & Brain

AI assessmentNot Hiring

No open roles listed right now. Follow Life & Brain to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

6 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

medical history

Myotonic Dystrophy 1

N/A

Clinical Trials (1)

NCT02729597Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up Study

N/A

Help build intelligence for Life & Brain

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Deep technical focus on neurology and cognitive science research with proprietary cellomics and genomics platforms
European biotech research environment with potential for academic collaboration and publishing
Early-stage pipeline across multiple neurology indications (Alzheimer's, PTSD, depression, stroke) with exploratory-stage programs

Watch Out For

No current open positions advertised (0 active jobs) signals limited hiring momentum or early-stage maturity
Minimal clinical advancement—only one Phase 1 program (Compassion Training for PTSD) with no Phase 2/3 data; most programs lack defined clinical phases
No disclosed revenue, funding, or financial metrics create transparency risk and unknown cash runway
Research-stage pipeline with non-traditional drug names ('DNA reports,' 'medical history') suggests early translational work, not commercial-ready assets

Generated by Claude from Life & Brain's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Client-centered ADL intervention

Stroke

N/A

Clinical Trials (1)

NCT01417585A Trial of a Client-centered Intervention Aiming to Improve Functioning in Daily Life After Stroke

N/A

DNA reports

Atopic Dermatitis

N/A

Clinical Trials (1)

NCT04965233Using a Telemedicine Approach in a Genome-wide Association Study of Atopic Dermatitis - Searching for Novel Biomarkers in Clinically Relevant Phenotypes

N/A

Online mindfulness based cognitive therapy intervention

Recurrent Major Depression

N/A

IONA Longitudinal Cohort Study

Alzheimer Disease

N/A

Clinical Trials (1)

NCT05892952IONA Longitudinal Cohort Study

N/A

Compassion Training

Prolonged Post-traumatic Stress Disorder